ArticleBiomarker insights2026

Circulating EMID2 as a Prognostic Biomarker of Poor Outcomes in Patients with Metastatic Colorectal Cancer.

Marina Crespo-Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.